RCKT
Rocket Pharmaceuticals Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$3.070
Máximo
$3.070
Mínimo
$3.070
Volume
3.11M
Fundamentos da empresa
Estatísticas de negociação
Notícias relacionadas
Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $11
Canaccord Genuity analyst Whitney Ijem maintains Rocket Pharmaceuticals with a Buy and lowers the price target from $34 to $11.
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.
B of A Securities Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $9
B of A Securities analyst Greg Harrison maintains Rocket Pharmaceuticals with a Buy and lowers the price target from $32 to $9.
BMO Capital Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $8
BMO Capital analyst Kostas Biliouris maintains Rocket Pharmaceuticals with a Outperform and lowers the price target from $30 to $8.
Scotiabank Maintains Sector Outperform on Rocket Pharmaceuticals, Lowers Price Target to $19
Scotiabank analyst Greg Harrison maintains Rocket Pharmaceuticals with a Sector Outperform and lowers the price target from $51 to $19.
Leerink Partners Downgrades Rocket Pharmaceuticals to Market Perform, Lowers Price Target to $8
Leerink Partners analyst Mani Foroohar downgrades Rocket Pharmaceuticals from Outperform to Market Perform and lowers the price target from $37 to $8.
Ações relacionadas
AWP
abrdn Global Premier Properties Fund Common Shares of Beneficial Interest
FATBP
FAT Brands Inc. 8.25% Series B Cumulative Preferred Stock
EVA
Enviva Inc.
RR
Richtech Robotics Inc.
LAB
Standard BioTools Inc.
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.